New hip stem put to the test in 95 patients

NCT ID NCT07616895

Not yet recruiting Disease control Sponsor: Medacta International SA Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test a new cementless hip stem (Mfinity collared stem) in 95 adults needing total hip replacement due to osteoarthritis. The main goal is to see how many implants survive without needing revision after one year, with a follow-up at two years. Researchers will track any revisions, deaths, or dropouts to estimate the implant's performance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mfinity collared femoral stem (a cementless hip implant device)
What this could lead to: If successful, this could provide a safe and effective new option for hip replacement surgery.
What could go wrong: This is a small, early-stage study with no control group, so results may not apply to all patients. The implant could fail or require revision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY OSTEOARTHRITIS OF THE HIP are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis, hip

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TOTAL HIP ARTHROPLASTY (THA)

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.